https://www.selleckchem.com/pr....oducts/Vorinostat-sa
There is limited data regarding the safety of vaginal delivery in women infected with COVID-19. Our goal was to assess the safety of vaginal delivery in women infected with COVID-19 and the risk of neonatal infection. This was a single medical center cohort study. Data were collected about the outcome of twenty-one women with laboratory-confirmed COVID-19 infection who delivered between March 23, 2020, and May 8, 2020. Twenty-one gravidas were diagnosed with COVID-19 infection. None required admission to the intensive care unit
Like
Comment
Share
